Entrectinib in the neoadjuvant setting of anaplastic thyroid cancer: a case report
Background: Anaplastic thyroid carcinoma (ATC) is one of the most aggressive solid tumors. ATC is frequently diagnosed at advanced stages with unresectable disease and palliative care is often indicated. Recently, several patient-tailored therapies for ATC are emerging due to advances in molecular p...
Main Authors: | Inês Damásio, Joana Simões-Pereira, Sara Donato, Mariana Horta, Branca Maria Cavaco, Miguel Rito, Pedro Gomes, Valeriano Leite |
---|---|
Format: | Article |
Language: | English |
Published: |
Bioscientifica
2023-01-01
|
Series: | European Thyroid Journal |
Subjects: | |
Online Access: | https://etj.bioscientifica.com/view/journals/etj/12/1/ETJ-22-0179.xml |
Similar Items
-
Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
by: Haruhiko Yamazaki, et al.
Published: (2023-02-01) -
Anaplastic Thyroid Cancer: Clinical Picture of the Last Two Decades at a Single Oncology Referral Centre and Novel Therapeutic Options
by: Joana Simões-Pereira, et al.
Published: (2019-08-01) -
SPRY4 as a Potential Mediator of the Anti-Tumoral Role of Macrophages in Anaplastic Thyroid Cancer Cells
by: Ana Teresa Pinto, et al.
Published: (2023-09-01) -
Development of Neuropathic Arthropathy With Entrectinib: Case Report
by: Nicholas P. Giustini, MD, et al.
Published: (2022-11-01) -
Prognosis of Anaplastic Thyroid Cancer with Distant Metastasis
by: Jin-Seok Lee, et al.
Published: (2022-11-01)